The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois.

Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c >7%).

Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM).

Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.

Inclusion Criteria:

• Patient receiving primary care from the study clinical site
• Uncontrolled T2DM (HbA1c >7%)
• 18 years of age and older

Exclusion Criteria:

• Patients younger than 18 years of age
• Patients in correctional facilities
• Pregnant or lactating women
• Current Continuous Glucose Monitoring device (CGM) users
• Patients with gestational diabetes mellitus or Type 1 diabetes mellitus

Due to the small size of the clinic, we are concerned about protecting the privacy of our patients. Deidentified data may be shared provided that any information that all information was anonymous.